Sánchez-Feliciano, Abizairie
Nock, Michael R.
Ershadi, Sherry
Barbieri, John S. https://orcid.org/0000-0002-5467-4102
Article History
Received: 1 December 2025
Accepted: 4 May 2026
First Online: 8 June 2026
Declarations
:
: John S Barbieri has received personal consulting fees from Alosa Health, Galderma, Honeydew Care, Sanofi Pasteur, Sagimet Biosciences, and Twi Biotechnology for work unrelated to the present submission. The authors declare no other competing interests.
: Institutional Review Board (IRB) approval for this project was obtained from the Mass General Brigham IRB (Protocol #2024P003621).